Biomanufacturing
Biomanufacturing is a type of manufacturing or biotechnology that utilizes biological systems to produce commercially important biomaterials and biomolecules for use in medicines, food and beverage processing, and industrial applications.
-
OCT 22, 2019 09:00 AM PDTC.E. CREDITSOCT 22, 2019 09:00 AM PDTDATE: October 22, 2019 TIME: 9:00am PDT, 12:00PM EDT...Speaker: Angela Bazigos , Kristeena Wright, PhD , Shweta NairSponsored By: Advanced InstrumentsAUG 14, 2019 09:00 AM PDTC.E. CREDITSAUG 14, 2019 09:00 AM PDTDATE: August 14, 2019TIME: 9:00am PT. 12:00pm ET Implementation of Lean Methodology in Biobanking Operations to standardize sample management processes is effective. Each proce...Speaker: Bill Lovatt , Jay Patel , Zachary KoglerSponsored By: Brooks Life SciencesJUL 30, 2019 06:00 AM PDTC.E. CREDITSJUL 30, 2019 06:00 AM PDTDATE: July 30, 2019TIME: 6:00am PT, 9:00am ET The current version of the EMA Guideline for the environmental risk assessment of human drugs was published in 2006. This guidance...Speaker: Erick Nfon, PhDSponsored By: SmithersJAN 31, 2019 01:30 PM PSTC.E. CREDITSJAN 31, 2019 01:30 PM PSTDevelopment of novel types of therapeutics require adaptation of traditional bioprocessing applications to include the use of primary cells, such as stem cells, fibroblasts, astrocytes and ne...Speaker: Simon Kaja, PhDPresented At:BioProcessing 2019JAN 31, 2019 12:00 PM PSTC.E. CREDITSJAN 31, 2019 12:00 PM PSTAs the pace of biotherapeutic approvals increases, so does the pressure on makers of new biologics to complete their development processes faster and more efficiently. The success of the drug...Speaker: Christopher Heger, PhDPresented At:BioProcessing 2019Sponsored By: Bio-TechneJAN 31, 2019 10:30 AM PSTC.E. CREDITSJAN 31, 2019 10:30 AM PSTMulti-mode chromatography has come to prominence in recent years due to the general utility of multi-mode ligands for product capture and polishing. In particular, their application in flow-t...Speaker: Buzz LobbezooPresented At:BioProcessing 2019Sponsored By: Prometic BioseparationsJAN 31, 2019 10:30 AM PSTC.E. CREDITSJAN 31, 2019 10:30 AM PSTThe Strep-Tactin®XT:Twin-Strep-tag®-purification system enables protein purification at high yields and purity under physiological conditions. Providing the highest binding affinity a...Speaker: Dennis Karthaus, MSPresented At:BioProcessing 2019JAN 31, 2019 09:00 AM PSTC.E. CREDITSJAN 31, 2019 09:00 AM PSTThe biologics development process is fraught with risks from pre-clinical studies through clinical evaluation. Prominent among these risks are changes in the critical quality attributes of th...Speaker: Jon Zmuda, PhDPresented At:BioProcessing 2019JAN 31, 2019 07:30 AM PSTC.E. CREDITSJAN 31, 2019 07:30 AM PSTProdrugs are harmless in their native state, as they are not targeted by human enzymes. But they can be converted into highly toxic compounds (the “drug”) by viral or bacterial en...Speaker: A.C. Matin, PhDPresented At:BioProcessing 2019JAN 31, 2019 06:00 AM PSTC.E. CREDITSJAN 31, 2019 06:00 AM PSTAmbrx’s mammalian expression platform (EuCODE™) enables non-native amino acids (nnAAs) through an expanded genetic code to both generate novel bio-therapeutics and to optimize the...Speaker: Weimin Lin, PhDPresented At:BioProcessing 2019OCT 11, 2018 01:30 PM PDTC.E. CREDITSOCT 11, 2018 01:30 PM PDTAs the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...Speaker: Benjamin Anderson, MDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 12:00 PM PDTC.E. CREDITSOCT 11, 2018 12:00 PM PDTLung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...Speaker: Nicholas McGranahan, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 10:30 AM PDTC.E. CREDITSOCT 11, 2018 10:30 AM PDTTwo projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...Speaker: Kevin Williams, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 09:00 AM PDTC.E. CREDITSOCT 11, 2018 09:00 AM PDTThe oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...Speaker: Jason De Melo, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 07:30 AM PDTC.E. CREDITSOCT 11, 2018 07:30 AM PDTIn the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...Speaker: Krastan Blagoev, PhDPresented At:Cancer Research & Oncology 2018OCT 11, 2018 06:00 AM PDTC.E. CREDITSOCT 11, 2018 06:00 AM PDTPacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...Speaker: Jonas Korlach, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 12:00 PM PDTC.E. CREDITSOCT 10, 2018 12:00 PM PDTRNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...Speaker: Jonathan Shaffer, MBA, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: QIAGENOCT 10, 2018 12:00 PM PDTC.E. CREDITSOCT 10, 2018 12:00 PM PDTTo date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...Speaker: Jerome Galon, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 09:00 AM PDTC.E. CREDITSOCT 10, 2018 09:00 AM PDTIn prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...Speaker: Paul Sondel, MD, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 09:00 AM PDTC.E. CREDITSOCT 10, 2018 09:00 AM PDTHigh-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...Speaker: Andrew Ravanelli, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: MilliporeSigmaOCT 10, 2018 07:30 AM PDTC.E. CREDITSOCT 10, 2018 07:30 AM PDTMolecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...Speaker: Karin Rodland, PhDPresented At:Cancer Research & Oncology 2018OCT 10, 2018 06:00 AM PDTC.E. CREDITSOCT 10, 2018 06:00 AM PDTUnderstanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...Speaker: Samuel Rulli, PhDPresented At:Cancer Research & Oncology 2018Sponsored By: QIAGENMAY 09, 2017 10:00 PM PDTMAY 09, 2017 10:00 PM PDTThe CSIRO Tissue Culture Facility (CTCF) employs a range of in-house optimized platform technologies to identify optimum vector-host cell combinations for both transient and stable protein pr...Speaker: George Lovrecz, PhDPresented At:2017 Gibco ExpressionWorldAUG 20, 2014 07:15 AM PDTAUG 20, 2014 07:15 AM PDTImagine a world in which we could adapt biology to manufacture any therapeutic, material, or chemical from renewable resources, both quickly and on demand. Industrial biotechnology is one of...Speaker: Michael C Jewett, PhDPresented At:Genetics and Genomics
OCT 22, 2019
09:00 AM PDT
C.E. CREDITS
OCT 22, 2019
09:00 AM PDT
DATE: October 22, 2019 TIME: 9:00am PDT, 12:00PM EDT...
Speaker:
Angela Bazigos
,
Kristeena Wright, PhD
,
Shweta Nair
Sponsored By: Advanced Instruments
AUG 14, 2019
09:00 AM PDT
C.E. CREDITS
AUG 14, 2019
09:00 AM PDT
DATE: August 14, 2019TIME: 9:00am PT. 12:00pm ET Implementation of Lean Methodology in Biobanking Operations to standardize sample management processes is effective. Each proce...
Speaker:
Bill Lovatt
,
Jay Patel
,
Zachary Kogler
Sponsored By: Brooks Life Sciences
JUL 30, 2019
06:00 AM PDT
C.E. CREDITS
JUL 30, 2019
06:00 AM PDT
DATE: July 30, 2019TIME: 6:00am PT, 9:00am ET The current version of the EMA Guideline for the environmental risk assessment of human drugs was published in 2006. This guidance...
Speaker:
Erick Nfon, PhD
Sponsored By: Smithers
JAN 31, 2019
01:30 PM PST
C.E. CREDITS
JAN 31, 2019
01:30 PM PST
Development of novel types of therapeutics require adaptation of traditional bioprocessing applications to include the use of primary cells, such as stem cells, fibroblasts, astrocytes and ne...
Speaker:
Simon Kaja, PhD
Presented At:BioProcessing 2019
JAN 31, 2019
12:00 PM PST
C.E. CREDITS
JAN 31, 2019
12:00 PM PST
As the pace of biotherapeutic approvals increases, so does the pressure on makers of new biologics to complete their development processes faster and more efficiently. The success of the drug...
Speaker:
Christopher Heger, PhD
Presented At:BioProcessing 2019
Sponsored By: Bio-Techne
JAN 31, 2019
10:30 AM PST
C.E. CREDITS
JAN 31, 2019
10:30 AM PST
Multi-mode chromatography has come to prominence in recent years due to the general utility of multi-mode ligands for product capture and polishing. In particular, their application in flow-t...
Speaker:
Buzz Lobbezoo
Presented At:BioProcessing 2019
Sponsored By: Prometic Bioseparations
JAN 31, 2019
10:30 AM PST
C.E. CREDITS
JAN 31, 2019
10:30 AM PST
The Strep-Tactin®XT:Twin-Strep-tag®-purification system enables protein purification at high yields and purity under physiological conditions. Providing the highest binding affinity a...
Speaker:
Dennis Karthaus, MS
Presented At:BioProcessing 2019
JAN 31, 2019
09:00 AM PST
C.E. CREDITS
JAN 31, 2019
09:00 AM PST
The biologics development process is fraught with risks from pre-clinical studies through clinical evaluation. Prominent among these risks are changes in the critical quality attributes of th...
Speaker:
Jon Zmuda, PhD
Presented At:BioProcessing 2019
JAN 31, 2019
07:30 AM PST
C.E. CREDITS
JAN 31, 2019
07:30 AM PST
Prodrugs are harmless in their native state, as they are not targeted by human enzymes. But they can be converted into highly toxic compounds (the “drug”) by viral or bacterial en...
Speaker:
A.C. Matin, PhD
Presented At:BioProcessing 2019
JAN 31, 2019
06:00 AM PST
C.E. CREDITS
JAN 31, 2019
06:00 AM PST
Ambrx’s mammalian expression platform (EuCODE™) enables non-native amino acids (nnAAs) through an expanded genetic code to both generate novel bio-therapeutics and to optimize the...
Speaker:
Weimin Lin, PhD
Presented At:BioProcessing 2019
OCT 11, 2018
01:30 PM PDT
C.E. CREDITS
OCT 11, 2018
01:30 PM PDT
As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 19...
Speaker:
Benjamin Anderson, MD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
12:00 PM PDT
C.E. CREDITS
OCT 11, 2018
12:00 PM PDT
Lung cancer is the leading cause of cancer-related mortality worldwide. Large-scale sequencing studies have revealed the complex genomic landscape of NSCLC and genomic differences between lun...
Speaker:
Nicholas McGranahan, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
10:30 AM PDT
C.E. CREDITS
OCT 11, 2018
10:30 AM PDT
Two projects looking at novel approaches to targeting inflammatory breast cancer will be presented. Inflammatory breast cancer (IBC) is a unique, understudied, and most lethal subtype account...
Speaker:
Kevin Williams, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
09:00 AM PDT
C.E. CREDITS
OCT 11, 2018
09:00 AM PDT
The oncogenic transcription factor c-MYC (MYC) is deregulated, and often overexpressed, in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease,...
Speaker:
Jason De Melo, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
07:30 AM PDT
C.E. CREDITS
OCT 11, 2018
07:30 AM PDT
In the past two decades a small number of infrequently dividing cells have been proposed as the source of multi-drug resistance during cancer treatment. These cells identified by their expres...
Speaker:
Krastan Blagoev, PhD
Presented At:Cancer Research & Oncology 2018
OCT 11, 2018
06:00 AM PDT
C.E. CREDITS
OCT 11, 2018
06:00 AM PDT
PacBio Sequencing simultaneously provides long sequence reads, high consensus accuracy, minimal sequence bias, and methylation detection. I will highlight new advances and updates on applying...
Speaker:
Jonas Korlach, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
12:00 PM PDT
C.E. CREDITS
OCT 10, 2018
12:00 PM PDT
RNA sequencing unlocks the mysteries hidden in the transcriptome. Whether your goal is gene expression analysis, gene fusion analysis, SNP analysis or miRNA expression analysis, achieving hig...
Speaker:
Jonathan Shaffer, MBA, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: QIAGEN
OCT 10, 2018
12:00 PM PDT
C.E. CREDITS
OCT 10, 2018
12:00 PM PDT
To date the anatomic extent of tumor (TNM-classification) has been by far the most important factors to predict the prognosis of cancer patients. However, this classification provides limited...
Speaker:
Jerome Galon, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
09:00 AM PDT
C.E. CREDITS
OCT 10, 2018
09:00 AM PDT
In prior work, we have pursued how tumor reactive monoclonal antibody (mAb), together with activators of innate immune cells, like NK cells, can augment antibody dependent cell-mediated cytot...
Speaker:
Paul Sondel, MD, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
09:00 AM PDT
C.E. CREDITS
OCT 10, 2018
09:00 AM PDT
High-throughput screening is widely useful in identifying genes and pathways that drive changes in cell behavior such as cell cycle regulation, metastasis, and drug resistance. Millipor...
Speaker:
Andrew Ravanelli, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: MilliporeSigma
OCT 10, 2018
07:30 AM PDT
C.E. CREDITS
OCT 10, 2018
07:30 AM PDT
Molecular analyses of cancer biology have tended to segregate between a focus on nucleic acids – DNA, RNA and their modifications – and a focus on proteins and protein function. P...
Speaker:
Karin Rodland, PhD
Presented At:Cancer Research & Oncology 2018
OCT 10, 2018
06:00 AM PDT
C.E. CREDITS
OCT 10, 2018
06:00 AM PDT
Understanding the immune repertoire is an important aspect of immuno-oncology research, which can be used to gather insights into the function and overall status of the immune system. We have...
Speaker:
Samuel Rulli, PhD
Presented At:Cancer Research & Oncology 2018
Sponsored By: QIAGEN
MAY 09, 2017
10:00 PM PDT
MAY 09, 2017
10:00 PM PDT
The CSIRO Tissue Culture Facility (CTCF) employs a range of in-house optimized platform technologies to identify optimum vector-host cell combinations for both transient and stable protein pr...
Speaker:
George Lovrecz, PhD
Presented At:2017 Gibco ExpressionWorld
AUG 20, 2014
07:15 AM PDT
AUG 20, 2014
07:15 AM PDT
Imagine a world in which we could adapt biology to manufacture any therapeutic, material, or chemical from renewable resources, both quickly and on demand. Industrial biotechnology is one of...
Speaker:
Michael C Jewett, PhD
Presented At:Genetics and Genomics
- Cannabinoid Research
- Neurotransmitters
- ADME
- Animal and Veterinary Sciences
- Food & Beverage
- Anxiety
- Cannabis Sciences
- Substances
- Veterinary Sciences
- Animal Research
- Animal Models
- Animal Sciences
- Food Science
- ALS
- Animal Behavior
- Marketing
- Animal Production
- Lab Animals
- Neuroscience
- Biologics
- Laboratory Testing
- Genetic Engineering
- Laboratory Animal Sciences
- In-Vivo Research
- Environmental Chemistry
- Point of Care
- Industrial
- Pharmaceuticals
- Serotonin
- Biomaterials
- Therapeutics
- Cell Signaling/Transduction
- Pollution
- Molecular Biology
- Engineering
- Biotechnology
- Genetics
- Pharmaceutical
- Immunology
